基础医学与临床 ›› 2021, Vol. 41 ›› Issue (10): 1446-1450.

• 研究论文 • 上一篇    下一篇

Nrf2激活剂缓解低氧性肺动脉高压大鼠肺血管重构

葛亮, 向悦华*, 谭旎   

  1. 恩施土家族苗族自治州中心医院 呼吸与危重症医学科, 湖北 恩施 445000
  • 收稿日期:2020-09-30 修回日期:2021-01-29 发布日期:2021-09-29
  • 通讯作者: *30701941@qq.com
  • 基金资助:
    湖北省自然科学基金(2017CFB769)

Nrf2 activator relieves pulmonary vascular remodeling in rats with hypoxic pulmonary arterial hypertension

GE Liang, XIANG Yue-hua*, TAN Ni   

  1. Department of Respiratory and Critical Medicine, the Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi 445000, China
  • Received:2020-09-30 Revised:2021-01-29 Published:2021-09-29
  • Contact: *30701941@qq.com

摘要: 目的 探讨核因子E2相关因子2(Nrf2)激活对低氧性肺动脉高压(PAH)大鼠血管重构的影响,并初步探讨其机制。方法 将大鼠分为:对照组、低氧组(低氧处理大鼠)、Nrf2激活组(低氧处理前1周每天灌胃5 mg/kg Nrf2激动剂莱菔硫烷,连续4周),每组8只。检测心肺血流动力学和右心室肥大指标平均肺动脉压(mPAP),并计算右心室肥厚指数=右心室(RV)/(左心室+室间隔)(LV+S);HE染色测定肺血管重构相关指标并计算肺小动脉血管壁面积(WA)/血管总面积(TA),血管中膜厚度(MT)/血管动脉外径(ED);硫代巴比妥酸法、氮蓝四唑法分别检测氧化应激指标丙二醛(MDA)、超氧化物岐化酶(SOD)活性;qRT-PCR检测肺动脉中基质金属蛋白酶(MMP)-2、MMP-9 mRNA水平;Western blot检测肺动脉组织中Nrf2、抗氧化反应元件(ARE)、磷酸酰胺腺嘌呤二核苷酸醌氧化还原酶-1(NQO-1)、血红素氧合酶1(HO1)蛋白水平。结果 与对照组相比,低氧组mPAP、RV/(LV+S),WA/TA、MT/ED水平,肺动脉组织中MDA水平,MMP-2、MMP-9 mRNA水平,胞核Nrf2、ARE、NQO1、HO1蛋白水平升高(P<0.05);肺动脉组织中SOD活性,胞质Nrf2蛋白水平降低(P<0.05)。与低氧组相比,Nrf2激活组mPAP、RV/(LV+S)水平,WA/TA、MT/ED水平,肺动脉组织中MDA水平,MMP-2、MMP-9 mRNA水平,胞质Nrf2蛋白水平降低(P<0.05);肺动脉组织中SOD活性,胞核Nrf2、ARE、NQO1、HO1蛋白水平升高(P<0.05)。结论 Nrf2激活可延缓PAH造成的血管重构,该作用可能是通过激活Nrf2/ARE通路实现的。

关键词: 活性氧, 氧化应激, 核因子E2相关因子2/血红素氧合酶1通路

Abstract: Objective To investigate the effect of activation of nuclear factor E2-related factor 2 (Nrf2) on vascular remodeling in hypoxic-induced pulmonary hypertension (PAH) rats and its mechanism. Methods The rats were divided into four groups with eight in each: control group, hypoxic group (hypoxic treatment of rats), Nrf2 activated group (gavage 5 mg/kg Nrf2 agonist sulforaphane every day for 4 weeks before hypoxic treatment). The cardiopulmonary hemodynamics and right ventricular hypertrophy index mean pulmonary artery pressure (mPAP) were measured, the right ventricular hypertrophy index=right ventricle (RV)/(left ventricle+interventricular septum) (LV+S) were calculated; the related indexes of pulmonary vascular remodeling were measured and the wall area (WA)/total area (TA) of pulmonary arterioles and the thickness of vascular mesothelium (MT)/external diameter (ED) of pulmonary arterioles were calculated; malondialdehyde (MDA) and superoxide dismutase (SOD) were measured by thiobarbituric acid method and nitrogen blue tetrazole method; the mRNA of matrix metalloproteinase (MMP) and MMP-9 in pulmonary artery were detected by qRT-PCR; and the protein level of Nrf2, antioxidant response element (ARE), NADPH quinineoxidoreductase-1 (NQO-1) and heme oxygenase1 (HO1) were measured by Western blot. Results Compared with the control group, the level of mPAP, RV/(LV+S), WA/TA and MT/ED, MDA and mRNA level of MMP-2 and MMP-9 in pulmonary artery tissue, the level of Nrf2, ARE, NQO1 and HO1 proteins in the nucleus of the hypoxic group were all increased (P<0.05); and SOD activity in pulmonary artery tissue and level of Nrf2 protein in plasma were decreased (P<0.05). Compared with hypoxia group, the levels of mPAP, RV/(LV+S), levels of WA/TA and MT/ED, level of MDA and mRNA levels of MMP-2 and MMP-9 in pulmonary artery tissue, the level of Nrf2 protein in cytoplasm of the Nrf2 activation group were decreased (P<0.05); and SOD activity in pulmonary artery tissue and levels of Nrf2, ARE, NQO1 and HO1 proteins in the nucleus were increased (P<0.05). Conclusions Nrf2 activation may delay the vascular remodeling induced by PAH, and potential mechanism is the pathway of Nrf2/ARE activation.

Key words: reactive oxygen species, oxidative stress, nuclear factor E2-associated factor 2/ heme oxygenase 1 pathway

中图分类号: